HNSA/N fundamentals
An in-depth look to HANSA BIOPHARMA AB operating, investing, and financing activities
HNSA/N free cash flow for Q1 24 is -292.95 M MXN. For 2023, HNSA/N free cash flow was -1.27 B MXN and operating cash flow was -1.27 B MXN.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: MXN
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM